State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now? [electronic resource]
Producer: 20190704Description: 3405-3412 p. digitalISSN:- 1791-7530
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Immunotherapy
- Pancreatic Neoplasms -- pathology
- Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.